Novartis Agrees to Buy Chinook for Up to $3.5 Billion
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
1970-01-01 08:00
Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028
Novartis AG’s generic-drug unit Sandoz could add $3 billion in sales over the next five years from its
1970-01-01 08:00
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
1970-01-01 08:00
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
1970-01-01 08:00